Body composition as predictor of toxicity and outcomes in patients with metastatic non-small cell lung cancer (mNSCLC) receiving nivolumab (Nivo).

被引：0
|
作者：
Shachar, Shlomit Strulov
Fried, Rachel
Shafran, Itamar
Moskovitz, Mor Tal
Williams, Grant Richard
Bar-Sela, Gil
Reiner-Benaim, Anat Strulov
Wollner, Mira
机构：
[1] Rambam Hlth Care Campus, Haifa, Israel
[2] Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada
[3] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA
[4] Rambam Hlth Care Campus, Harduf, Israel
[5] Rambam Hlth Care Campus, Div Oncol, Haifa, Israel
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21010
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Disadvantaged subgroups of metastatic non-small cell lung cancer (mNSCLC) patients treated with nivolumab.
    Rossi, Sabrina
    Finocchiaro, Giovanna
    Toschi, Luca
    Santoro, Armando
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [2] Variation in neutrophil to lymphocyte ratio (NLR) as predictor of outcomes in metastatic renal cell carcinoma (mRCC) and non-small cell lung cancer (mNSCLC) patients treated with nivolumab
    A. Simonaggio
    R. Elaidi
    L. Fournier
    E. Fabre
    V. Ferrari
    D. Borchiellini
    J. Thouvenin
    P. Barthelemy
    C. Thibault
    E. Tartour
    S. Oudard
    Y. A. Vano
    Cancer Immunology, Immunotherapy, 2020, 69 : 2513 - 2522
  • [3] Variation in neutrophil to lymphocyte ratio (NLR) as predictor of outcomes in metastatic renal cell carcinoma (mRCC) and non-small cell lung cancer (mNSCLC) patients treated with nivolumab
    Simonaggio, A.
    Elaidi, R.
    Fournier, L.
    Fabre, E.
    Ferrari, V.
    Borchiellini, D.
    Thouvenin, J.
    Barthelemy, P.
    Thibault, C.
    Tartour, E.
    Oudard, S.
    Vano, Y. A.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (12) : 2513 - 2522
  • [4] Outcomes of Patients with Metastatic Non-Small Cell Lung Cancer (MNSCLC) with Brain Metastases Treated with Pembrolizumab
    Sun, L.
    Davis, C.
    Marmarelis, M.
    Singh, A.
    Berman, A.
    Feigenberg, S.
    Levin, W.
    Bauml, J.
    Cohen, R.
    Langer, C.
    Aggarwal, C.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : S1131 - S1131
  • [5] Prediction of the efficacy of nivolumab using resting energy expenditure in metastatic non-small cell lung cancer (mNSCLC) patients
    Gervais, Claire
    Boudou-Rouquette, Pascaline
    Jouinot, Anne
    Chapron, Jeanne
    Arrondeau, Jennifer
    Alifano, Marco
    Giraud, Frederique
    Huillard, Olivier
    Alexandre, Jerome
    Vazeille, Clara
    Durand, Jean-Philippe
    Leroy, Karen
    Revel, Marie-Pierre
    de Bandt, Jean-Pascal
    Cynober, Luc
    Damotte, Diane
    Lupo-Mansuet, Audrey
    Goldwasser, Francois
    CANCER RESEARCH, 2018, 78 (13)
  • [6] COGNITIVE CONCERNS AND PERFORMANCE IN PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER (mNSCLC)
    Eggen, Annemarie
    Richard, Nadine
    Shen, Gerald
    Shultz, David
    Leighl, Natasha
    Liu, Geoffrey
    Sun, Alexander
    Bosma, Ingeborg
    Reyners, Anna
    Jalving, Mathilde
    Rodin, Gary
    Edelstein, Kim
    NEURO-ONCOLOGY, 2019, 21 : 159 - 159
  • [7] Experience of nivolumab and pembrolizumab in metastatic non-small cell lung cancer in routine clinical practice (mNSCLC.)
    Ksienski, Doran
    Brooks, Edward Geoffrey
    Fenton, Dave
    Fiorino, Leathia
    Geller, Georgia Samantha
    Poonja, Zia
    Glick, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] FDA analysis of outcomes in Asian patients (pts) with metastatic non-small cell lung cancer (mNSCLC) receiving immune checkpoint inhibitors (ICI).
    Chang, Elaine
    Gong, Yutao
    Vallejo, Jonathon Joseph
    Liu, Qi
    Mathieu, Luckson Noe
    Booth, Brian
    Sridhara, Rajeshwari
    Beaver, Julia A.
    Pazdur, Richard
    Blumenthal, Gideon Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [9] Real World Clinical Outcomes for Metastatic Non-Small Cell Lung Cancer (mNSCLC) at IRST Italy
    Altini, M.
    Massa, I.
    Balzi, W.
    Gentili, N.
    Foca, F.
    Danesi, V.
    Manunta, S.
    Ejzykowicz, F.
    Chandwani, S.
    Burgio, M.
    Cravero, P.
    Verlicchi, A.
    Bronte, G.
    Crino, L.
    Delmonte, A.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1065 - S1066
  • [10] Metastatic site as a predictor of nivolumab efficacy in patients with advanced non-small cell lung cancer: A retrospective multicenter trial
    Tamiya, Motohiro
    Tamiya, Akihiro
    Inoue, Takako
    Kimura, Madoka
    Kunimasa, Kei
    Nakahama, Kenji
    Taniguchi, Yoshihiko
    Shiroyama, Takayuki
    Isa, Shun-ichi
    Nishino, Kazumi
    Kumagai, Toru
    Suzuki, Hidekazu
    Hirashima, Tomonori
    Atagi, Shinji
    Imamura, Fumio
    PLOS ONE, 2018, 13 (02):
12345